| Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment HM Mortensen, J Chamberlin, B Joubert, M Angrish, N Sipes, JS Lee, ... Mammalian genome 29, 190-204, 2018 | 24 | 2018 |
| Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors YJ Jin, S Byun, S Han, J Chamberlin, D Kim, MJ Kim, Y Lee BMC medical genomics 12, 1-12, 2019 | 15 | 2019 |
| Differences in molecular sampling and data processing explain variation among single-cell and single-nucleus RNA-seq experiments ARQ JT Chamberlin, Y Lee, GT Marth | 11* | 2024 |
| Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein YJ Jin, HM Aycheh, S Han, J Chamberlin, J Shin, S Byun, Y Lee BMC Medical Genomics 13, 1-11, 2020 | 4 | 2020 |
| No evidence for whole-chromosome dosage compensation or global transcriptomic expression differences in spontaneously-aneuploid mutation accumulation lines of Saccharomyces … HC McQueary, MG Behringer, S Demario, AJJ Canas, B Johnson, ... bioRxiv, 2020.12. 01.404830, 2020 | 2 | 2020 |
| Best practices to evaluate the impact of biomedical research software—metric collection beyond citations A Afiaz, AA Ivanov, J Chamberlin, D Hanauer, CL Savonen, MJ Goldman, ... Bioinformatics 40 (8), 2024 | 1* | 2024 |
| Improved characterization of single-cell RNA-seq libraries with paired-end avidity sequencing JT Chamberlin, AE Gillen, AR Quinlan bioRxiv, 2024.07. 10.602909, 2024 | | 2024 |
| Persistent gene expression and DNA methylation alterations linked to carcinogenic effects of dichloroacetic acid G Carswell, J Chamberlin, BD Bennett, PR Bushel, BN Chorley Frontiers in Oncology 14, 2024 | | 2024 |
